
TransMedics Group Reports Q3 Revenue of $143.8 Million and Net Income of $24.3 Million

I'm PortAI, I can summarize articles.
TransMedics Group Inc. reported Q3 2025 revenue of $143.8 million, a 32% increase from Q3 2024, with a net income of $24.3 million ($0.66 per diluted share). The company raised its full-year 2025 revenue guidance to $595-$605 million, reflecting 36% growth at the midpoint. As of September 30, 2025, TransMedics held $466.2 million in cash and owned 21 aircraft, increasing to 22 by October 29, 2025. They also announced a collaboration with Mercedes-Benz Group AG for organ transportation in Italy.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

